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Mouse hepatitis virus (MHV) JHMV and its soluble receptor-resistant (srr) mutants, srr7, srr11, and srr18, grew and
induced syncytia equally well in BHK-R1 cells expressing the MHVR1 receptor derived from MHV-susceptible BALB/c
mice. In contrast, srr growth and syncytia formations were drastically reduced relative to wild-type (wt) virus in BHK-R2
cells expressing the MHVR2 receptor from MHV-resistant SJL mice. Infections by these srr mutants in BHK-R2 cells
were 0.7 to 1.5 log10 less efficient than those of wt virus. BHK cells expressing both MHVR1 and MHVR2 supported srr
replication to the same extent as did BHK-R1 cells, suggesting that inefficient infection by srr mutants in BHK-R2 cells
resulted from the absence of the effective receptor MHVR1. Virus-receptor binding tests failed to demonstrate a
difference between the abilities of wt and srr18 to bind MHVR2. The binding of srr7 and srr11 to both MHVR1 and
MHVR2 was revealed lower by two- to fourfold relative to the wt binding. The fusion activity of srr S proteins as
examined by the expression with recombinant vaccinia virus was apparently lower than that of the wt S protein in
BHK-R2 cells, while there was not such a remarkable difference in BHK-R1 cells. This suggests that the most likely
reason for inefficient infection by mutants in BHK-R2 is impaired virus entry into cells. These observations suggest that
inefficient infections in BHK-R2 cells by srr mutants occur in the absence of a functional receptor MHVR1, which plays
an important role in srr entry into cells. © 2000 Academic PressINTRODUCTION
Mouse hepatitis virus (MHV) belongs to the coronavi-
rus family of enveloped, positive-stranded RNA viruses.
The genomic RNA of MHV is about 32 kilobases in length
and encodes four structural proteins: the 50- to 60-kDa
nucleocapsid protein, the 20- to 25-kDa integral mem-
brane glycoprotein, the 150- to 200-kDa spike (S) glyco-
protein, and an envelope protein of about 10 kDa. An-
other structural protein, found in some coronaviruses, is
the hemagglutinin-esterase protein, which is expressed
on MHV JHMV. Coronaviruses also encode several dif-
ferent species of nonstructural proteins (Spaan et al.,
1988; Lai and Cavanagh, 1997).
Spikes projecting from the virion surface are made up
of the S protein. A spike consists of two or three mole-
cules of the S protein, each of which is a heterodimer of
two noncovalently bound subunits, S1 and S2 (Lai and
Cavanagh, 1997; Sturman et al., 1985). The S1 and S2
subunits are derived by cleavage of the precursor S
protein from its N- and C-terminal halves (Sturman et al.,
1985). The S1 subunit forms the globular part of the spike
and the S2 its stalk portion (De Groot et al., 1987). The S
rotein has multiple functions. The fusion of cultured
ells infected with MHV is caused by the S protein
Collins et al., 1982; Taguchi et al., 1992), although the
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80region responsible for fusion activity is not thoroughly
understood. Some regions in the S2 subunit have been
reported to be active sites for fusion activity (Gallager et
al., 1991; Gallager, 1996; Luo and Weiss, 1998). Un-
cleaved S protein has a fusion activity (Stauber et al.,
1993; Taguchi, 1993), suggesting that the mechanism of
fusion formation by MHV differs from that of other fuso-
genic RNA viruses, which undergo cleavage (White,
1990). MHV-2 fusion activity is reported to require cleav-
age (Yamada et al., 1997). Among its other functions, the
S protein elicits neutralizing antibodies and cytotoxic T
cells in MHV-infected mice (Castro and Perlman, 1995;
Flory et al., 1993) and is a major determinant of viral
virulence in animals (Dalziel et al., 1986; Fleming et al.,
1986; Matsubara et al., 1991; Phillips et al., 1999; Taguchi
et al., 1995; Wang et al., 1992).
The MHV S protein binds to a member of the carcino-
embryonic antigen (CEA) gene family called the virus-
specific receptor protein (Dveksler et al., 1991; Williams
et al., 1991). The S1 but not S2 subunit is responsible for
receptor binding (Kubo et al., 1994; Taguchi, 1995; Suzuki
and Taguchi, 1996) as might be expected from the topol-
ogies of these subunits (De Groot et al., 1987). The
receptor binding site of the MHV S protein is located in
the N-terminal domain of the S1 subunit and consists of
330 amino acids (S1N330) (Kubo et al., 1994). Some of
the amino acid residues responsible for receptor-binding
activity were identified using S1N330 mutants generated
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81IMPAIRED ENTRY OF MHV INTO BHK-R2 CELLSby site-directed mutagenesis (Suzuki and Taguchi, 1996)
and by other mutant MHV studies (Saeki et al., 1997).
Three different mouse proteins, biliary glycoprotein 1
(Bgp1, newly named CEACAM1) (Dveksler et al., 1991,
1993; Yokomori and Lai, 1992a; Beauchemin et al., 1999),
Bgp2 (newly named CEACAM2) (Nedellec et al., 1994;
Beauchemin et al., 1999), and brain CEA (bCEA) (Chen et
al., 1995), all of which are CEA gene family members,
function as receptors for MHV. Of these, Bgp1 has the
highest receptor activity. Bgp1 has two allelic forms,
Bgp1a (MHVR1, newly named CEACAM1a) and Bgp1b
(MHVR2, newly named CEACAM1b) (Yokomori and Lai,
1992b; Dveksler et al., 1993; Beauchemin et al., 1999).
nbred mouse strains which are highly susceptible to
HV, BALB/c, and C57BL express MHVR1, while MHV-
esistant SJL mice express MHVR2 (Boyle et al., 1987;
veksler et al., 1993; Ohtsuka and Taguchi, 1997).
HVR2 has been shown by us and others to be a less
ffective receptor than MHVR1 when receptor activity
as examined in cultured cells (Chen and Baric, 1996;
htsuka et al., 1996; Rao et al., 1997). We reported that
the difference in susceptibility to JHMV infection be-
tween BALB/c and SJL mice is likely to be a function of
the MHV receptor (Ohtsuka and Taguchi, 1997).
We have several soluble receptor-resistant (srr) mu-
tants, which are resistant to neutralization with the sol-
uble receptor MHVR1 (soMHVR1) (Saeki et al., 1997).
Srr11 has an amino acid change at position 65 in the S1
(Leu to His), while srr7 and srr18 have mutations at
FIG. 1. Fusion indices of wt and mutants in BHK-R1 and BHK-R2 cells
BHK-R1 or BHK-R2 cells infected with wt cl-2 or srr mutants at an m.o.i.
and eosin and photographed under a light microscope. Fused cell
[1-(cells/nuclei)] were calculated. (B) Amounts of MHVR1 and MHVR2 ex
The same amounts of lysate of BHK-R1 (1), BHK-R2 (2), and control BHK
with anti-MHV receptor antibodies No. 655. The binding of the antibodpositions 1114 (Leu to Phe) and 1164 (Cys to Phe) in the
S2, respectively. These mutants use the MHVR1 receptor
B
Mexpressed on the cell membrane just as efficiently as
does the wild-type (wt) virus, although they resist neu-
tralization with soMHVR1 (Saeki et al., 1997). We report
here that srr mutants infected cultured cells expressing
MHVR1 as efficiently as wt virus, yet failed to efficiently
infect cells expressing MHVR2. Our results suggest that
inefficient infection by srr mutants in these cells is due to
defects in viral entry into cells.
RESULTS
Syncytia formation and growth of srr mutants
in BHK-R1 and BHK-R2 cells
MHVR1 is derived from an MHV-susceptible BALB/c
mouse, while MHVR2 is from an MHV-resistant SJL
mouse. The isolated srr mutants, which are able to re-
sist neutralization by soMHVR1, can infect cells ex-
pressing MHVR1. In this study, we extended our earlier
study to examine whether srr mutants can infect cells
that express the less functional receptor, MHVR2.
BHK-R1 and BHK-R2 cells express constitutively MHVR1
(CEACAM1a-2S consisting of two domains and short
ytoplasmic tail) (Beauchemin et al., 1999) and MHVR2
CEACAM1b-2S consisting of two domains and short
ytoplasmic tail) (Beauchemin et al., 1999), respectively.
he amount of MHVR1 in BHK-R1 cells was 1.04 times
igher than that of MHVR2 in BHK-R2 cells as examined
y Western blot analysis using anti-MHV receptor anti-
odies No. 655 (Fig. 1B). This shows that BHK-R1 and
d MHV receptor levels expressed on BHK-R1 and BHK-R2 cells (B). (A)
re fixed at intervals after infection. Cells were stained with hematoxylin
nuclei were counted in several different fields, and fusion indices
d in BHK-R1 and BHK-R2 cells were examined by Western blot analysis.
3) were prepared on membrane paper by Western blotting and reacted
s detected with HRPO-labeled anti-rabbit IgG by ECL.(A) an
5 1 we
s and
presseHK-R2 cells express equivalent amounts of MHVR1 and
HVR2 proteins. These cells were infected with wt cl-2
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82 MATSUYAMA AND TAGUCHIor srr mutants at a multiplicity of infection (m.o.i.) of 1 and
their ability to induce syncytia was compared. In BHK-R1
cells, syncytia formation was first detected at 8 h posti-
noculation (p.i.), and almost all of the cells were included
in syncytia by 12 h irrespective of the infecting virus (Fig.
1A). In contrast, syncytia formation in BHK-R2 cells in-
fected with either wt cl-2 or srr18 was first detected at
12 h p.i., while no syncytia were observed at this time in
either srr7- or srr11-infected cells. Nearly 90% of BHK-R2
cells infected with wt virus were fused by 18 h p.i., while
only about 20 to 30% of cells infected with srr18 were
fused. Strikingly, at 18 h p.i. only about 5% of cells in-
fected with srr7 or srr11 showed fusion (Fig. 1A). At 36 h
p.i., 70 to 80% of BHK-R2 cells infected with srr18 were
included in syncytia, while less than 20% of cells dis-
played syncytia when infected with srr7 or srr11 (data not
shown).
To determine whether this difference in syncytia for-
mation was due to differences in the growth potentials of
wt and srr mutants, BHK-R1 and BHK-R2 cells were
infected with each virus (m.o.i. 5 1) and at intervals after
inoculation virus titers were determined by plaque as-
says. As shown in Figs. 1 and 2, there was an apparent
correlation between viral titer and fusion formation in
both BHK-R1 and BHK-R2 cells. In BHK-R1 cells, all of the
viruses grew at similar rates; their progeny viruses were
first detected at 9 h p.i. and titers reached a peak of
105.2–5.5 PFU/0.1 ml at 15 to 18 h p.i. These patterns of
rowth and syncytia formation in BHK-R1 cells are sim-
lar to those previously reported for these viruses in DBT
ells expressing MHVR1 (Saeki et al., 1997). In BHK-R2
ells, however, the patterns were different; significant
ifferences in titers were seen for some srr viruses in
ells expressing this receptor. Wt cl-2 grew well and
eached a peak of 105.3 PFU/0.1 ml by 18 h, while srr7,
srr11, and srr18 showed 103.8, 103.8, and 104.5 PFU/0.1 ml,
FIG. 2. Growth of wt and mutants in BHK-R1 and BHK-R2 cells. BHK
intervals after infection, cells and culture fluids were harvested togethe
the virus titer in the supernatants was determined by plaque assays.espectively. Srr mutants reached a peak at 24 h p.i.
hese results demonstrated that srr mutants were capa-le of growing in BHK-R1 cells as efficiently as wt virus,
hile their growth in BHK-R2 cells was 0.7 to 1.5 log10
ess than that of wt virus. Srr18 showed the tendency to
row better in BHK-R2 cells with a high passage history
han those cells with a low passage history. Although
ess remarkably different in growth than the srr mutants
n the two cell types, wt cl-2 also showed a significant
issimilarity in growth and cytopathology when grown in
HK-R1 and BHK-R2. This difference in MHV growth
etween cells expressing MHVR1 and those expressing
HVR2 confirms earlier reports (Ohtsuka et al., 1996;
ao et al., 1997).
laquing efficiency and infectious center assay of srr
utants on BHK-R1 and BHK-R2 cells
We have examined the plaquing efficiency of the vi-
uses on BHK-R1 and BHK-R2 cells. These cell lines
ere infected with 10-fold serial dilutions of wt cl-2 and
he srr mutants, and the number of plaques produced
as compared. As shown in Fig. 3, there was a distinct
BHK-R2 cells were infected with wt or srr mutants at an m.o.i. 5 1. At
reeze–thawed three times. After centrifugation to clear cellular debris,
FIG. 3. Plaquing efficiencies of wt and mutants in BHK-R1 and
BHK-R2 cells. Wt cl-2 and srr mutants were serially diluted 10-fold and
inoculated onto BHK-R1 or BHK-R2 cells. The cells were cultured for
48 h in DMEM containing 0.5% methylcellulose and plaques were-R1 orcounted after staining with neutral red. The vertical line extending
above each bar indicates the standard deviation of three samples.
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83IMPAIRED ENTRY OF MHV INTO BHK-R2 CELLSdifference (1.5 to 2.5 log10) between wt and srr mutants
plaque numbers in BHK-R2 cells, while no significant
difference was observed in BHK-R1 cells. Figure 3 also
shows that differences in plaquing efficiencies of the srr
mutants were 2.5 to 3.5 log10 when grown in BHK-R1 and
BHK-R2 cells, while the difference was only 1 log10 in
these cells with wt cl-2. These results demonstrate that
infection of srr mutants in BHK-R1 cells is similar in
efficiency to wt cl-2, while their infection in BHK-R2 cells
is remarkably inefficient.
The infection of wt and srr viruses was also analyzed
by infectious center assays. BHK-R1 and BHK-R2 cells,
as well as control BHK cells, were infected with either wt
cl-2 or srr mutants (m.o.i. 5 1). After a 3-h incubation,
nfected cells were washed with PBS containing 0.05%
ween 20 and then trypsinized. Tenfold serial dilutions of
he resulting single cell suspension were overlaid onto
BT cells and the plaques were counted at 15 h p.i. As
hown in Fig. 4, there was no apparent difference among
t and srr mutants in the numbers of infectious centers
btained with BHK-R1 cells. However, striking differ-
nces were observed between wt virus and srr mutants
rown in BHK-R2 cells. Srr7 and srr11 were shown to
nfect BHK-R2 cells 1.0 to 1.5 log10 less efficiently com-
ared with wt cl-2 virus. The infection efficiency of srr18
as 0.7 log10 lower than that of wt cl-2 in BHK-R2 cells.
hese results suggest that cl-2 and srr mutant infections
ccur with similar efficiency in BHK-R1 cells, but srr
utants infect BHK-R2 cells extremely inefficiently. All of
he wt and srr mutants showed the same level of back-
round, 102.5 to 103 infectious centers in BHK cells. This
may not imply that these viruses infected BHK cells
FIG. 4. Infectious centers produced by wt and mutants on BHK-R1
and BHK-R2 cells. BHK-R1, BHK-R2, and BHK cells were infected with
wt cl-2 and srr mutants at an m.o.i. 5 1 and cultured for 3 h. Cells were
washed twice with PBS containing 0.5% BSA and 0.05% Tween 20. After
trypsin treatment, 10-fold serial dilutions of the cells were overlaid onto
DBT cell monolayers and cultured in DMEM containing 0.5% methyl-
cellulose for 15 h. The plaques were counted after staining with neutral
red. The vertical line extending above each bar indicates the standard
deviation of three samples.lacking MHV receptor, but could imply that these viruses
were not washed away, since we could not detect theinfected BHK cells by immunofluorescence (data not
shown).
Susceptibility of BHK cells expressing both MHVR1
and MHVR2
The inefficient infection of srr mutants in BHK-R2 cells
could be an effect of MHVR2 receptor which influences
srr replication in BHK cells but does not effect wt virus
replication. To examine this possibility, MHVR1 was ex-
pressed on BHK-R2 cells and MHVR2 on BHK-R1 cells.
Transfection efficiencies in these cells were examined
by the expression of b-galactosidase from cotransfected
CMV-b-gal. More than 90% of both BHK-R1 and BHK-R2
ells were revealed to express the b-galactosidase by in
situ staining and the b-galactosidase levels were not
ifferent between BHK-R1 cells transfected with the
HVR2 gene and BHK-R2 cells transfected with the
HVR1 gene, respectively (data not shown). This
howed that there was no remarkable difference in
ransfection efficiencies between these cells. As shown
n Fig. 5, all srr mutants grew well and induced syncytia
n both BHK-R1 cells transiently expressing MHVR2 and
HK-R2 cells transiently expressing MHVR1; in fact, the
rowth of srr viruses and their cytopathic effects on cells
oexpressing MHVR1 and MHVR2 were indistinguish-
ble from those on BHK-R1 cells constitutively express-
ng MHVR1 alone. The infection of all mutants in BHK-R1
ells was not prevented by the expression of MHVR2.
hese results suggest that inefficient infection by srr
utants in BHK-R2 cells is not due to the suppressive
ffect of MHVR2 in their replication, but most likely due to
he lack of an efficient receptor protein.
inding of srr mutants to MHVR1 and MHVR2
Since the experimental data described above sug-
ested that the difference in growth between wt cl-2 and
FIG. 5. Virus susceptibility of BHK-R1 cells transfected with an
MHVR2 expression construct and BHK-R2 cells transfected with an
MHVR1 expression construct. BHK-R1 and BHK-R2 cells were trans-
fected with vectors harboring the MHVR2 and MHVR1 genes, respec-
tively. Two days later, these cells were infected with wt or srr mutants
at an m.o.i. 5 1 and virus titers in cells were determined at 18 h p.i. by
plaque assays. The vertical line extending above each bar indicates the
standard deviation of three samples.
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84 MATSUYAMA AND TAGUCHIthe srr mutants in BHK-R2 cells is related to their inter-
action with MHVR2, we examined the direct binding of
these viruses to MHVR2. We have previously compared
the binding of wt virus to MHVR1 and MHVR2 by a viral
overlay protein blot assay (VOPBA) (Ohtsuka et al., 1996);
in those experiments, binding of wt cl-2 to MHVR2 was
not detectable. Since VOPBAs show the binding of virus
to reduced and denatured receptor proteins, the results
of these experiments might not reflect the physiological
interaction of the receptor and virus. Consequently, an
alternative method has been utilized here to detect virus
bound to receptors expressed on BHK cells. BHK-R1,
BHK-R2, and BHK cells were overlaid with either wt or srr
virus and incubated at 37°C for 1 h. After washing, the S
proteins bound to cells were quantified by dot blotting as
FIG. 6. Virus-binding analysis to the MHVR1 and MHVR2 expressed
n BHK cell membrane. (A) BHK-R1, BHK-R2, and BHK cells prepared in
2 well-plate were overlaid with 50 ml of wt or srr mutants containing
1 3 105 PFU and incubated at 37°C for 1 h. The cells were further
incubated in the presence [BS(1)] or absence [BS(2)] of the
crosslinker BS3 at RT for 30 min. The cells were vigorously washed and
the S proteins bound to the cells were measured as described under
Materials and Methods by ECL using S1-specific MAb. (B) BHK-R1,
BHK-R2, and BHK cells were overlaid with twofold serial dilutions of wt
or srr mutants and incubated in the presence of BS3 as described
above. The amounts of S proteins bound to BHK-R1 and BHK-R2 cells
were determined as described under Materials and Methods.described under Materials and Methods. As shown in
Fig. 6A BS(2), wt cl-2 as well as srr mutants were
F
edetected in lysate from BHK-R1, but not BHK-R2. The
failure to detect even wt cl-2 in the BHK-R2 lysate could
be due to extremely labile or weak binding to MHVR2. To
address this possibility, a crosslinker BS3 was used to
orm crosslinks between viruses and MHVR2. After incu-
ation under the conditions described above, these cells
ere treated with the BS3 at room temperature (RT) for 30
in. After vigorous washing, the S proteins bound to
ells were quantified by dot blotting. As shown in Fig. 6A
S(1), wt and srr S proteins were detected in the BHK-R2
ysate. There was no difference between wt and srr18 in
heir ability to bind to BHK-R2 when assayed in the
resence of crosslinker. The binding ability of srr7 and
rr11 was two- to fourfold weaker relative to the wt ability.
owever, these values were very similar to those ob-
erved in the binding to MHVR1 [Fig. 6, MHVR1 BS(1)];
rr18 bound to MHVR1 with the same efficiency as wt, yet
rr7 and srr11 did two- to fourfold less efficiently. We
ave repeated similar experiments at least three times
nd obtained almost identical results. It was clear that
nefficient infection of srr18 in BHK-R2 cells did not result
rom its low binding. Inefficient infections of srr7 and -11
ould be mediated by their low binding to MHVR2 in view
f the facts that MHVR2 has a very low affinity to MHVs
elative to MHVR1 (Ohtsuka et al., 1996; Rao et al., 1997).
The binding to MHVR2 in the presence of crosslinker
was specific, since no binding was observed when BHK
cells were examined.
We have also examined whether the binding detected
in the presence of BS3 was concentration-dependent.
Twofold step diluted viruses were overlaid onto BHK-R1
or BHK-R2 cells and incubated in the presence of the
crosslinker. The amounts of crosslinked S protein were
measured as described under Materials and Methods.
As shown in Fig. 6B, the intensity of their binding varied
in a concentration-dependent fashion both in BHK-R1
and in BHK-R2 cells, although it was shown again that
the binding of srr7 and srr11 to both MHVR1 and MHVR2
was four- to eightfold less efficient compared with that of
wt and srr18. Specific binding to both MHVR1 and
MHVR2 in the presence of BS3 was again evident.
ntry of srr mutants into BHK-R1 and BHK-R2 cells
Since the above data suggest that srr mutants bind to
oth MHVR1 and MHVR2 with similar efficiency, we have
xamined their entry into these cells. As a marker of viral
ntry potential, the fusogenicity of these srr S proteins
as examined. The S genes of wt and srr were ligated
nto the pTarget vector, which has a T7 promoter up-
tream of the S gene. These vectors were transfected
nto BHK-R1 or BHK-R2 cells that were then infected with
TF7.3; fusion indices of infected cells were calculated
s described under Materials and Methods. As shown in
ig. 7A, wt and srr mutants induced syncytia with similar
fficiencies in BHK-R1 cells. The fusion index of BHK-R2
w
M
W
a
B
w
c
m
e
c
w
r
n
n of thr
85IMPAIRED ENTRY OF MHV INTO BHK-R2 CELLScells, however, was remarkably low when srr S proteins,
but not wt S proteins, were expressed. Srr7 and srr11 S
protein fusion activity in BHK-R2 cells was at least 80%
less than in BHK-R1 cells, while the fusogenicity of srr18
was about 70% less than in BHK-R1 cells. The fusoge-
nicity of wt in BHK-R2 was about 20% less than in BHK-R1
cells. The finding that srr7 and srr11 fusion activity was
reduced to a greater degree than that of srr18 or wt is
compatible with the degree of their lesser efficiency of
infection in BHK-R2 cells. Further, their apparent differ-
ences in fusogenicity cannot be accounted for by protein
expression level, since the amounts of S proteins syn-
thesized in BHK-R2 and BHK-R1 cells were not remark-
ably different between wt and srr mutants as examined
by Western blotting; the amounts of the srr S proteins
were in the range of 80 to 110% compared to those of wt
virus S protein (Fig. 7B). These findings show that the srr
S proteins have greatly reduced fusion activity in BHK-R2
cells, although they are almost identically fusogenic to wt
in BHK-R1 cells.
From the findings shown above, we have tentatively
concluded that wt virus could enter into BHK-R2 cells
more efficiently than could the srr mutants, which was
demonstrated by their different fusogenicities. The differ-
ence in srr entry efficiency between BHK-R1 and BHK-R2
cells could account for their inefficient infection of
BHK-R2 cells.
DISCUSSION
Srr mutants with a single amino acid mutation in the S
FIG. 7. Fusion activity of wt and srr S proteins in BHK-R1 and BHK-R
a T7-vaccinia virus expression system. The fusogenicity (A) of these
vertical line extending above each bar indicates the standard deviatio
blotting using anti-S MAb and ECL.proteins showed low fusion activity as well as depressed
growth in cells expressing MHVR2, although these mu-
p
btants had a fusion and growth potential similar to wt cl-2
in cells expressing MHVR1. In this study, we have ana-
lyzed the mechanisms underlying inefficient infection by
srr mutants in BHK-R2 cells in comparison with the wt
virus. Since the infection defect of mutants in BHK-R2
cells was overcome by transiently expressing the high-
efficiency receptor MHVR1 on BHK-R2 cells, it is clear
that MHVR1 is indispensable for efficient srr replication,
presumably at the stage of virus–receptor interaction. In
agreement with this hypothesis, both srr mRNA and
protein expression in BHK-R2 cells, which occur after
viral entry, were reduced significantly compared with
those in BHK-R1 cells (data not shown).
We have previously tried to detect direct JHMV–M-
HVR2 interaction by VOPBA, but its binding was barely
detectable; it was 0.2% or less than its binding to MHVR1
by this assay (Ohtsuka et al., 1996). In the present study,
e have examined the binding of the viruses to the
HVR1 and MHVR2 expressed on cultured BHK cells.
e have used the crosslinker BS3 to quantify the
mounts of both wt and srr viruses that bound to cultured
HK-R2 cells, since even wt cl-2 binding to these cells
as under detectable levels in the absence of the
rosslinker. In this modified binding assay, wt and srr18
utant were revealed to bind to BHK-R2 to the same
xtent. Srr7 and srr11 bound two- to fourfold less effi-
iently. The reduced binding of these two srr mutants
as also observed in the binding to MHVR1. These
esults suggest that inefficient infection by srr mutants is
ot due to their reduced binding to MHVR2. However, the
. Wt and srr S proteins were expressed in BHK-R1 and BHK-R2 using
ins was measured as described under Materials and Methods. The
ee samples. The amount (B) of S proteins was compared by Western2 cells
S proteossibility cannot be excluded that the slightly reduced
inding of srr7 and srr11 to MHVR2 is responsible for
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86 MATSUYAMA AND TAGUCHIinefficient infection, although the same degree of re-
duced binding to MHVR1 did not affect their infection.
Since MHVR2 has far weaker virus-binding activity com-
pared with MHVR1 as shown in this and earlier studies
(Ohtsuka et al., 1996; Rao et al., 1997), two- to fourfold
less binding of these two mutants could be below the
threshold necessary to establish the efficient infection in
BHK-R2 cells.
We have further examined the fusogenicity of their S
proteins in an attempt to analyze the entry process in
BHK-R2 cells. The fusogenicity of srr mutants was ap-
parently reduced in BHK-R2 cells relative to wt cl-2, even
though they caused almost the same degree of fusion in
BHK-R1 cells. The reduced binding of srr7 and srr11 to
MHVR2 as described above could be partly, if not totally,
involved in the reduced fusogenicity of their S proteins. In
conclusion, it is most likely that inefficient infection by srr
mutants in BHK-R2 cells is a result of inefficient viral
entry into cells. Although the fusogenicity of each virus
could represent the viral entry activity, more direct tests
would help accurately estimate the activity.
The findings with srr18 inefficient infection and possi-
bly other two mutants infection reported in this paper
suggest an additional, important function for the recep-
tor, that is, the receptor plays a crucial role not only in
virus binding, but also in the subsequent viral entry stage
in MHV infection. In a recent report studying poliovirus
(PV), Arita et al. reported that the chimeric PV receptor
(PVR), which consists of the extracellular domain of PVR
and the Fc portion of mouse IgG, bound to PV as effi-
ciently as anti-PV MAb IgG and that the chimeric recep-
tor mediated PV infection far more efficiently in cells
expressing the mouse Fc receptor than did an anti-PV
MAb (Arita et al., 1999). The difference in the efficiency of
infections established by chimeric PVR and anti-PV MAb
was assumed to depend on virion alteration activity
rather than virus-binding activity (Arita et al., 1999). These
observations in two considerably different viruses, non-
enveloped PV and enveloped MHV, show that interac-
tions between virus and receptor or receptor-like mole-
cules can greatly influence the subsequent steps of viral
replication. While it could be a common feature of a wide
variety of viruses that virus–receptor interaction influ-
ences subsequent viral entry into cells, it is not yet
evident exactly how the interaction between MHV and its
receptors influences viral entry.
As is supposed for PV–PVR interaction, interaction of
MHV and its receptor could induce conformational
changes in the S protein that may be important for fusion
activity. The binding of mutants and wt virus to MHVR1 is
far tighter than their binding to MHVR2, as shown in this
and earlier studies (Ohtsuka et al., 1996; Rao et al., 1997).
This suggests that srr S proteins may become fusogenic
when bound to a high-affinity receptor, but not when
bound to a low-affinity receptor, while the wt S protein
becomes fusogenic even when bound to a low-affinity
lreceptor. Although the mechanism by which this differ-
ence in fusogenicity is generated has not yet been ad-
dressed, it is likely that binding to either a high- or a
low-affinity receptor causes the conformational changes
of wt S protein which result in virus–cell membrane
fusion. Srr mutants, however, might not undergo such
conformational changes after binding to the low-affinity
receptor because of the mutations in their S protein.
As a conformational change of the S protein following
the binding to the receptor, the dissociation of S1 and S2
subunits is known (Gallagher, 1997; Saeki et al., 1997).
We have previously reported that the S1 subunits of srr
mutants do not dissociate from the S2 subunits after they
bind to the MHVR1 receptor, while the wt cl-2 S1 disso-
ciates very easily from S2 (Saeki et al., 1997). The S1 and
S2 association was very tight for srr7 and srr11, while it
was less tight for srr18 (Saeki et al., 1997). Interestingly,
the tightness of S1 and S2 association for a particular
virus directly correlates with its inefficiency of replication
in BHK-R2 cells as shown in this study. This observation
suggests the possibility that the dissociation of S1 from
S2 after binding to the receptor is an important event
restricting MHV infection in BHK-R2 cells, but not infec-
tion in BHK-R1 cells. Studies are currently in progress to
test this possibility.
MATERIALS AND METHODS
Viruses and cells
MHV strain JHMV cl-2 (wt cl-2) (Taguchi et al., 1985)
and srr mutants (srr7, srr11, srr18) resistant to neutraliza-
tion by soMHVR1 (Saeki et al., 1997) were used. Srr11
has an amino acid change in the S1 subunit at position
65 (Leu to His). Srr7 and -18 have a change in the S2
subunit at positions 1114 (Leu to Phe) and 1163 (Cys to
he), respectively (Saeki et al., 1997). Virus stocks were
repared from the culture fluids of infected DBT cells.
irus titers were determined by plaque assays using
BT cells as previously reported (Hirano et al., 1974;
Taguchi et al., 1980). DBT, RK-13 (RK), BHK-21 (BHK),
BHK-R1, and BHK-R2 cell lines were used for these stud-
ies. BHK cells are not susceptible to MHV, while BHK-R1
and BHK-R2 cells, which constitutively express either the
MHVR1 (CEACAM1a-2S) or MHVR2 (CEACAM1b-2S)
Beauchemin et al., 1999), respectively, are susceptible.
he latter two cell lines were produced by transfection of
HK cells with plasmid vector pKS336 containing either
he MHVR1 or the MHVR2 gene as previously reported
Saeki et al., 1997); the BHK-R1 and BHK-R2 cell lines
sed in this study are the cloned cell lines which were
he most sensitive to infection by wt cl-2. The amounts of
HVR1 and MHVR2 expressed in BHK-R1 and BHK-R2
ere examined by Western blot analysis using rabbit
nti-MHV receptor polyclonal antibodies No. 655 (Wil-iams et al., 1990) (kindly provided by Dr. K. Holmes). The
reactivity of No. 655 to MHVR1 was 1.02 times higher
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87IMPAIRED ENTRY OF MHV INTO BHK-R2 CELLSthan that to MHVR2 when examined using these receptor
proteins tagged with a myc epitope in their C terminus
and anti-myc MAb. The plasmids to express receptor
proteins with the myc epitope were constructed accord-
ing to the previously described method to tag an influ-
enza HA epitope (Ohtsuka et al., 1997). These cell lines
were grown and maintained in Dulbecco’s modified Ea-
gle’s minimal essential medium (DMEM) (Nissui, Tokyo,
Japan) supplemented with 5% fetal calf serum (FCS)
(Gibco BRL, Grand Island, NY) under 5% CO2.
usion index
Approximately 5 3 105 BHK-R1 or BHK-R2 cells pre-
pared in 12-well plates (Costar, Cambridge, MA) were
infected at an m.o.i. of 1 with either srr mutants or wt cl-2.
After 1 h of adsorption at 37°C, 1 ml of DMEM containing
5% FCS was added, followed by incubation at 37°C. At
various intervals following infection, cells were fixed with
10% formaldehyde, stained with hematoxylin and eosin,
and photographed under a light microscope (Olympus
BH-2, Tokyo, Japan). A total of more than 500 nuclei and
fused cells was counted in several different fields from
each picture and fusion indices [1-(cells/nuclei)] were
calculated as described by Gallagher et al. (1991).
Plaquing efficiency
Confluent BHK-R1 and BHK-R2 cells prepared in
35-mm culture dishes (Costar) were infected with 10-fold
serial dilutions of virus stock, containing from 100 to 105
PFU of either srr mutants or wt cl-2. After 1 h of adsorp-
tion at 37°C, cells were overlaid with Eagle’s minimal
essential medium (Nissui) containing 1% FCS, 10% tryp-
tose phosphate broth (TPB) (Difco, Detroit, MI), and 0.5%
methylcellulose (4000 cP) (Sigma, St. Louis, MO). After
48 h of incubation, plaques were stained with neutral red
and counted.
Infectious center assay
BHK-R1, BHK-R2, and BHK cells prepared in 35-mm
dishes were infected with srr mutants or wt cl-2 (m.o.i. 5
1) and incubated at 37°C for 1 h. After washing twice
with phosphate-buffered saline (PBS), pH 7.2, containing
0.5% bovine serum albumin and 0.05% Tween 20, the
cells were incubated in DMEM supplemented with 3%
FCS at 37°C for 3 h. In some cases, the cells were
treated with monoclonal antibody (MAb) No. 3, a neutral-
izing antibody against cl-2 S1 (Kubo et al., 1993), to
horoughly neutralize the remaining viruses. The cells
ere then treated with 0.25% trypsin at 37°C for 3 min
nd collected by spinning at 1500 rpm for 5 min. After
hree washes with DMEM, 10-fold dilutions of infected
ells in 0.1 ml of DMEM were overlaid onto confluent
BT cells prepared in 35-mm dishes. The cells were
ultured with DMEM supplemented with 0.5% methylcel-lulose and 10% TPB for 15 h at 37°C, and plaques were
counted after being stained with neutral red.
Transient expression of MHVR1 in BHK-R2 cells and
MHVR2 in BHK-R1 cells
Approximately 1 3 107 BHK-R1 or BHK-R2 cells in 600
ml DMEM were mixed with 10 mg of a pTarget mamma-
lian expression vector (Promega, Madison, WI) encoding
either MHVR2 or MHVR1, respectively, together with 10
mg pCMVb, which encodes b-galactosidase under con-
rol of the cytomegalovirus promoter (Clontech, Palo Alto,
A). After electroporation with a Gene Pulser electropo-
ator (Bio-Rad, Hercules, CA), the cells were cultured in
MEM containing 5% FCS for 2 days. The cells were
hen examined for their sensitivity to viral infection. To
stimate transfection efficiencies, the percentage of
ells expressing b-galactosidase was examined by in
situ staining as reported previously (Nussbaum et al.,
1994) and the amount of b-galactosidase expressed in
he cells was measured with the b-galactosidase en-
yme assay system kit (Promega), as suggested by the
anufacturer’s instructions.
estern blotting
Western blot analysis was carried out as previously
eported (Saeki et al., 1997). Briefly, cell lysates in PBS
ontaining 0.65% Nonidet P-40 (lysing buffer) were elec-
rophoresed in a 10% SDS polyacrylamide gel and the
roteins were electrically transferred onto an Immobilon
ransfer membrane (Millipore, Bedford, MA). After treat-
ent with Block-Ace (Yukijirushi, Sapporo, Japan), the
lot was incubated for 1 h at RT with MAb 10G specific
or the S2 subunit (Routledge et al., 1991), kindly provided
y S. G. Siddell. The MAb was diluted 1:5000 with PBS
efore use. Antibody binding was detected with horse-
adish peroxidase (HRP)-conjugated anti-mouse or anti-
abbit IgG antibodies (Cappel Organon Teknica, Durham,
C). The bands were visualized on X ray film using
nhanced chemiluminescence (ECL) reagents (Amer-
ham, Arlington Heights, IL) and the density of each band
as measured by NIH Image (a public domain software)
o compare the amounts of the S protein.
protein binding to MHV receptors expressed at the
ell membrane
Fifty microliters of virus stock containing 1 3 105 PFU
of either wt or srr mutants was inoculated onto confluent
(approximately 5 3 105 cells) BHK-R1, BHK-R2, or BHK
ells prepared in 12-well plates. After incubation at 37°C
or 1 h, 50 ml of either PBS or the crosslinking reagent
bis(sulfosuccinimidyl) suberate] (BS3) (Pierce), at a final
concentration of 10 mM, was added to each well and
incubated at RT for 30 min. After three washes with
DMEM, cells were lysed with 50 ml of lysing buffer. The
protein concentration of the lysates was measured by a
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88 MATSUYAMA AND TAGUCHIcommercial kit (Bio-Rad, protein assay). To estimate the
amount of S protein bound to the receptors on the cell
surface, the lysates with same protein concentration
were twofold step diluted and dotted onto Immobilon
membrane. In some experiments, twofold step dilutions
of either wt or srr mutants were inoculated onto BHK-R1,
BHK-R2, or BHK cells and treated with BS3 as described
bove. Lysates were prepared from those cells and dot-
ed onto the membrane as described above. After treat-
ent with Block-Ace, those membranes were incubated
or 1 h at RT with biotin-conjugated MAb No. 7 (Kubo et
l., 1993). The antibody bound to the S protein was
etected using an avidin–HRP conjugate using ECL re-
gents and visualized on X ray film as described above.
onstruction of expression vectors containing the S
enes and their expression by vTF7.3
DNA encoding the wt S protein was amplified by
olymerase chain reaction (PCR) from the original wt S
ene (Taguchi et al., 1992) using a forward primer [S-5-
os-HD, 59-CGCAAGCTTCTAAACATGCTGTTC-GT-39]
orresponding to the sequence around the S gene initi-
tion codon and a reverse primer [S-3-N-HD-Neg, 59-
AGCTTTCCAGGAGAGGCTGTGA-39] corresponding to
he complementary sequence around its termination
odon. This PCR product was ligated into the pTarget
ector in the downstream the T7 promoter to create
Tar-cl-2S. The pTar-cl-2S construct contains three
mino acid mutations, compared with the original S
ene, at positions 286 (Ser to Thr), 722 (Glu to Asp), and
95 (Ala to Ser), although it exhibits fusion activity similar
o the original S protein. The cDNAs of the srr S genes
ere prepared by reverse transcription-PCR (Yamada et
l., 1993) with the primers S-5-Pos-HDS and S-3-N-HD-
eg, as described above, and cloned into the pTarget
ector. To make srr S constructs that are identical to
Tar-cl-2S in all respects other than their single muta-
ions, we have in each case below substituted the seg-
ent that contains the srr mutation for the corresponding
egment of pTar-cl-2S. To make the srr11 S gene expres-
ion construct, a 0.3-k basepair (bp) BamHI–PmeI frag-
ent of pTar-cl-2S, corresponding to the region contain-
ng the srr11 mutation, was replaced with the same
ragment derived from the srr11 cDNA. To construct the
rr7 and srr18 S genes, a 1.3-k bp NruI–SalI fragment of
Tar-cl-2S, corresponding to the region containing both
he srr7 and srr18 mutations, was replaced with the
ame fragment from either the srr7 or srr18 S gene,
espectively. These srr S genes were sequenced to con-
irm the absence of unexpected mutations by dideoxy
hain termination sequencing as described previously
Sanger et al., 1977). The pTarget vectors containing
ither the wt or the various mutant S genes were ex-
ressed in BHK-R1 and BHK-R2 cells using vTF7.3Fuerst et al., 1986), kindly provided by B. Moss, as
reviously reported (Saeki et al., 1997).
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